Status:
UNKNOWN
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
Lead Sponsor:
Medical University of Graz
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-85 years
Brief Summary
By combining clinical, morphological and biochemical markers a better understanding of the formation and progression of multiple sclerosis (MS) should be obtained
Detailed Description
The current study aims to comprehensively investigate the individual clinical, morphological and biochemical aspects of MS in order to elucidate underlying mechanisms leading to disease progression. T...
Eligibility Criteria
Inclusion
- Patients with suspected or proven multiple sclerosis
- The participants are patients who are in inpatient or outpatient care of the Department of Neurology at the Medical University of Graz, Austria
Exclusion
- Excluded from the examinations are all patients for whom an MRI examination is impossible or problematic
Key Trial Info
Start Date :
October 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04892134
Start Date
October 3 2019
End Date
October 31 2025
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Styria, Austria, 8010